Ten samples of antiserum against Pseudomonas cepacia were prepared by the intravenous immunization of rabbits with heat-killed organisms. Ten P. cepacia strains used for immunization were proven unique antigenic strains. Using these antisera, we serogrouped 127 strains of P. cepacia, and 114 strains (89.8%) fell under one of the ten serogroups. The most prevalent serogroup was C (26.8%), the Pseudomonas cepacia is a motile, glucose-nonfermentative gram-negative bacillus able to use a large number of substrates at a wide range of temperatures. Although it is rarely a serious pathogen, P. cepacia has recently been isolated with increasing frequency from clinical specimens in hospitals, especially from those of patients with severe underlying disease (1, 6, 7). Nosocomial infections with P. cepacia were also reported in several hospitals (1, 9, 10, 13 (12) . Immunization of rabbits with P. cepacia was carried out as follows. P. cepacia strains were grown on heart infusion agar at 37°C for 18 h. The organisms were collected, and 100 mg of the organisms was suspended in 1 ml of 0.15 M phosphatebuffered saline (pH 7.2); the organisms were then killed by heating at 100°C for 1 h. Successive single intravenous injections of 1, 2, 3, and 5 mg of organisms into adult rabbits * Corresponding author.
were carried out at 1-week intervals. At 1 week after the last immunization, the rabbits were sacrificed for collection of antisera. Antibody against P. cepacia was titrated by an agglutination test with heat-killed organisms. A serial twofold dilution of the antisera was carried out with 0.15 M phosphate-buffered saline by use of microtiter plates. A 25-pul amount of diluted serum was combined with the same volume of a suspension of heat-killed organisms (2 mg/ml in phosphate-buffered saline), incubated at 37°C for 2 h, and then allowed to stand at 4°C for 16 h. The highest dilution of antiserum which showed agglutination was determined to be the antibody titer. To determine the serogroups of the strains which were agglutinated with more than one antiserum, the antisera were absorbed with heat-killed organisms. The precise absorption procedure was described by us previously (11) .
First, we chose seven P. cepacia strains isolated at different places in Japan and prepared antisera against them. From these antisera, we obtained three specific antisera which were later designated anti-C, anti-D, and anti-E. Thereafter, several other strains were tested for agglutination in three specific antisera. From nonagglutinable strains, we selected a few strains for immunization, and then we prepared other antisera. In this way, we prepared 10 specific antisera and their immunogen strains. The 10 antisera thus prepared were examined for reciprocal antibody titration with 10 P. cepacia strains used as immunogens (Table 1) . These antisera, designated anti-A to anti-J, had high antibody titers against homologous strains but very low antibody titers against all of the heterologous strains.
Three strains each of P. aeruginosa, P. putida, P. maltophilia, P. fluorescens, P. stutzeri, and Achromobacter xylosoxidans were tested against 10 antisera, but there was no reaction.
We tested 127 P. cepacia strains for serogrouping with 10 antisera; i.e., the antibodies of 10 antisera for 127 an absorption test (11) . The distribution of the 127 strains among the serogroups is shown in Table 2 . The most prevalent serogroup was C (26.8%); the second most prevalent serogroup was D (18.1%). Serogroups C, D, E, and F were the four major serogroups and corresponded to 62.3% of the strains tested. From the geographical point of view, the distribution of the strains and serogroups was as follows.
The city and number of strains of serogroup C found there were: Yamagata, 10 strains; Tokyo, 8 strains; Fukushima, 5 strains; Tochigi, 2 strains; and other places, including the United States, the United Kingdom, and France, 9 strains. The city and number of strains of serogroup D found there were: Osaka, 11 strains; other places in Japan, 8 strains; the United States and France, 4 strains. All of the strains belonging to serogroups E and F were isolated at Fukushima city and Hirosaki city, respectively. We also prepared antisera against P. cepacia strains used for the serogrouping of Monteil et al. (4, 8) and performed cross-agglutination with our standard strains and antisera. As a result, serogroup 0-1 of Monteil et al. (4, 8) corresponded to our serogroup D, their serogroup 0-2 corresponded to our serogroup G, their serogroup 0-3 corresponded to our serogroup I, their serogroup 0-4 corresponded to our serogroup C, and their serogroup 0-7 corresponded to our serogroup A. However, their serogroups 0-5 and 0-6 did not correspond to any of our serogroups (Table  2) . In the present study, we examined the serogrouping of P. cepacia as an epidemiological tool and individualized 10 monospecific antigens among P. cepacia strains. Almost 90% of the 127 total strains were classified under one of the 10 serogroups. Strains belonging to serogroup C were mostly isolated in the east part of Japan (Yamagata, Tokyo, Fukushima, and Tochigi prefectures), and half of the strains of serogroup D were isolated in the west part of Japan (Osaka prefecture). However, some strains in both C and D serogroups were isolated in the United States and France. Serogroup E and F appear to be peculiar to certain geographical areas in Japan, but for further research we need a wider range and greater number of samples of the strains. As a result of cross-agglutination tests between strains and antisera, we clarified the relationship between our serogroups and those of Monteil et al. (4, 8 
